Xylem Raises FY2026 Adj EPS Guidance from $5.35-$5.60 to $5.55-$5.70 vs $5.54 Est; Narrows FY2026 Sales Guidance from $9.200B-$9.300B to $9.200B vs $9.254B Est

Benzinga Newsdesk www.benzinga.com Positive 85.8%

Neg 0% Neu 0% Pos 85.8%

Xylem (NYSE:XYL) raises FY2026 Adj EPS guidance from $5.35-$5.60 to $5.55-$5.70 vs $5.54 analyst estimate. Narrows FY2026 sales outlook from $9.200 billion-$9.300 billion to $9.200 billion vs $9.254 billion estimate.